ATE353331T1 - Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin - Google Patents

Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin

Info

Publication number
ATE353331T1
ATE353331T1 AT04796445T AT04796445T ATE353331T1 AT E353331 T1 ATE353331 T1 AT E353331T1 AT 04796445 T AT04796445 T AT 04796445T AT 04796445 T AT04796445 T AT 04796445T AT E353331 T1 ATE353331 T1 AT E353331T1
Authority
AT
Austria
Prior art keywords
triazolo
pyrazolo
pyrimidine
amino
producing substituted
Prior art date
Application number
AT04796445T
Other languages
English (en)
Inventor
Shen-Chun Kuo
David Jieh-Shyh Tsai
Loc Thanh Tran
Pengyi Zhang
Andrew D Jones
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE353331T1 publication Critical patent/ATE353331T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT04796445T 2003-10-28 2004-10-26 Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin ATE353331T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51505103P 2003-10-28 2003-10-28

Publications (1)

Publication Number Publication Date
ATE353331T1 true ATE353331T1 (de) 2007-02-15

Family

ID=34572798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04796445T ATE353331T1 (de) 2003-10-28 2004-10-26 Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin

Country Status (18)

Country Link
US (4) US7223861B2 (de)
EP (1) EP1678182B1 (de)
JP (2) JP4782693B2 (de)
CN (2) CN1898246B (de)
AR (1) AR046560A1 (de)
AT (1) ATE353331T1 (de)
CA (1) CA2543431A1 (de)
CY (1) CY1106393T1 (de)
DE (1) DE602004004677T2 (de)
DK (1) DK1678182T3 (de)
ES (1) ES2278353T3 (de)
HR (1) HRP20070063T3 (de)
MX (1) MXPA06004722A (de)
PL (1) PL1678182T3 (de)
PT (1) PT1678182E (de)
SI (1) SI1678182T1 (de)
WO (1) WO2005044819A1 (de)
ZA (1) ZA200603307B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1283839T1 (de) * 2000-05-26 2005-08-31 Schering Corp
PT1678182E (pt) * 2003-10-28 2007-04-30 Schering Corp Processo para preparar 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pirimidinas
EP1902716A4 (de) * 2005-06-07 2009-05-13 Kyowa Hakko Kirin Co Ltd Prophylaktisches und/oder therapeutisches mittel für motorische störungen
EP2462144B1 (de) 2009-08-07 2017-09-20 Merck Sharp & Dohme Corp. Verfahren zur herstellung eines 2-alkinyl substituierten 5-amino-pyrazolo-[4, 3-e]-1,2,4-triazolo [1,5-c] pyrimidins
US20110144049A1 (en) * 2009-10-21 2011-06-16 Serebruany Victor L Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
WO2013168196A1 (ja) 2012-05-10 2013-11-14 ユニテクノ株式会社 半導体搬送テスト治具
SG10201806450SA (en) * 2014-09-26 2018-09-27 Hoffmann La Roche PROCESSES FOR PREPARING (CYCLOPENTYL[d]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS
WO2020106560A1 (en) 2018-11-20 2020-05-28 Merck Sharp & Dohme Corp. Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
WO2020106558A1 (en) 2018-11-20 2020-05-28 Merck Sharp & Dohme Corp. Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
CR20210271A (es) 2018-11-30 2021-07-14 Merck Sharp & Dohme Derivados de amino triazolo quinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmacéuticas y su uso
JP2022511778A (ja) 2018-11-30 2022-02-01 メルク・シャープ・アンド・ドーム・コーポレーション アデノシン受容体拮抗薬としての7-、8-及び10-置換されたアミノトリアゾロキナゾリン誘導体、医薬組成物及びそれらの使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039733A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 5-aminopyrazole
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
SI1283839T1 (de) 2000-05-26 2005-08-31 Schering Corp
CN1491227A (zh) 2001-02-05 2004-04-21 株式会社大V制药工厂 三唑并喹唑啉和吡唑并三唑并嘧啶衍生物、医药组合物、腺苷 a 3受体亲和剂、降眼压剂、预防和治疗青光眼的制剂及降低眼压的方法
MXPA03010002A (es) * 2001-05-01 2004-06-30 Fujisawa Pharmaceutical Co Compuestos de cefemo.
US6916811B2 (en) * 2001-11-30 2005-07-12 Schering Corporation Adenosine A2a receptor antagonists
PT1678182E (pt) * 2003-10-28 2007-04-30 Schering Corp Processo para preparar 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pirimidinas
JP2007513091A (ja) * 2003-12-01 2007-05-24 シェーリング コーポレイション 置換された5−アミノ−ピラゾロ−[4,3−e]−1,2,4−トリアゾロ[1,5−c]ピリミジンを調製するための方法

Also Published As

Publication number Publication date
CY1106393T1 (el) 2011-10-12
CN101899050A (zh) 2010-12-01
US7601833B2 (en) 2009-10-13
DK1678182T3 (da) 2007-06-04
ES2278353T3 (es) 2007-08-01
US20050090492A1 (en) 2005-04-28
US20090326241A1 (en) 2009-12-31
CN1898246A (zh) 2007-01-17
SI1678182T1 (sl) 2007-06-30
DE602004004677D1 (de) 2007-03-22
HRP20070063T3 (hr) 2007-04-30
EP1678182A1 (de) 2006-07-12
WO2005044819A1 (en) 2005-05-19
PL1678182T3 (pl) 2007-05-31
US7223861B2 (en) 2007-05-29
US20090005559A1 (en) 2009-01-01
PT1678182E (pt) 2007-04-30
JP4782693B2 (ja) 2011-09-28
JP2007509948A (ja) 2007-04-19
ZA200603307B (en) 2008-07-30
CN1898246B (zh) 2010-10-27
DE602004004677T2 (de) 2007-11-15
JP2011116795A (ja) 2011-06-16
MXPA06004722A (es) 2006-07-05
EP1678182B1 (de) 2007-02-07
US7439361B2 (en) 2008-10-21
US20070203340A1 (en) 2007-08-30
HK1086008A1 (en) 2006-09-08
AR046560A1 (es) 2005-12-14
CA2543431A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
ATE498621T1 (de) Verfahren zur herstellung substituierter pyrimidine
ATE340819T1 (de) Verfahren zur herstellung von polyamiden
DE60324720D1 (de) Verfahren zur Herstellung dekorativer Gegenstände
DE602005026478D1 (de) Verfahren zur Herstellung von dünnwandigen Isogittergehäusen
DE60330050D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
ATE397608T1 (de) Verfahren zur herstellung von anagrelid
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
EP1778419A4 (de) Verfahren zur herstellung von extrusionswerkzeugen
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
DK1678182T3 (da) Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
ATE377599T1 (de) Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE431339T1 (de) Verfahren zur herstellung von n-amino- substituierten heterocyclischen verbindungen
DE602004000126D1 (de) Verfahren zur Herstellung von selbststanzenden Muttern
ATE404506T1 (de) Verfahren zur herstellung poröser sinterformkörper
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE433965T1 (de) Verfahren zur herstellung von enantiomerenreinem mirtazapin
DE60333466D1 (de) Verfahren zur herstellung von aluminiumnitrid-sinterkörpern
ATA332003A (de) Verfahren zur herstellung von metallschaumkörpern
ATE438631T1 (de) Verfahren zur herstellung von reinem melamin
DE502004007419D1 (de) Verfahren zur Herstellung von Radschüsseln
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE349442T1 (de) Verbessertes verfahren zur herstellung von alpha- polymorphem eletriptan hydrobromid
ATE501282T1 (de) Verfahren zur herstellung von konzentraten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1678182

Country of ref document: EP